Yahoo Finance

Nextbiomedical Publishes Landmark Study in GUT Demonstrating Nexpowder™ Significantly Reduces Rebleeding After Endoscopic Hemostasis

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...
조선일보

Next Biomedical ships hemostatic agent Nexpowder to Japan for endoscopy use

Next Biomedical announced on the 17th that it has completed the first shipment of its hemostatic agent for endoscopy, Nexpowder, to Japan. Nexpowder received product approval from the Pharmaceuticals ...
아시아경제

[Click eStock] "NextBio, FDA Approval Expected for Major Indication in Second Half of This Year"

LS Securities forecasted on the 22nd that sales of Nextbiomedical will rapidly increase as the market penetration rate of NexPowder rises. Jo Eun-ae, a researcher at LS Securities, explained, ...
Medscape

FDA Clears Nexpowder Endoscopic Hemostasis System

The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...
Healio

Top in GI: Endoscopic hemostasis system; FDA panel vote on C. difficile treatment

Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared the endoscopic hemostasis system Nexpowder, which is intended to improve visibility and ...
Becker's ASC

FDA clears Medtronic gastrointestinal bleeding solution

Nexpowder is a noncontact, nonthermal and nontraumatic powder that can treat upper gastrointestinal bleeding, according to a Sept. 28 news release from the company shared with Becker’s. Seventy-five ...